Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

Blood tests measure the level of PSA protein, produced by the prostate gland, and may help detect early signs of prostate ...

Recovering erections grabs the attention of most men and their doctors after prostate cancer treatment. A new study redirects ...

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...

Men who avoided prostate cancer screening appointments were significantly more likely to die from the disease, according to ...

Moderately hypofractionated and conventionally fractionated radiotherapy demonstrate similar efficacy, but one ...

The Bishop of Manchester has revealed he has been diagnosed with prostate cancer. The Right Reverend David Walker said the ...

The new surgical method, called NeuroSAFE, preserves the nerves that run through the prostate’s outer layers, which are ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said it has given a world-first approval to Rotop's ...